Literature DB >> 34697487

MSI-H/dMMR mCRC: ICIs in the first line?

Peter Sidaway1.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 34697487     DOI: 10.1038/s41571-021-00576-z

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Randomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406).

Authors:  Scott Kopetz; Katherine A Guthrie; Van K Morris; Heinz-Josef Lenz; Anthony M Magliocco; Dipen Maru; Yibing Yan; Richard Lanman; Ganiraju Manyam; David S Hong; Alexey Sorokin; Chloe E Atreya; Luis A Diaz; Carmen Allegra; Kanwal P Raghav; Stephen E Wang; Christopher H Lieu; Shannon L McDonough; Philip A Philip; Howard S Hochster
Journal:  J Clin Oncol       Date:  2020-12-23       Impact factor: 50.717

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.